Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
Quest Diagnostics (DGX) Net Income towards Common Stockholders Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.72% |
| Mar 31, 2026 | -11.28% |
| Jun 30, 2024 | 64.38% |
| Dec 31, 2022 | -15.15% |
| Sep 30, 2022 | 10.22% |
| Jun 30, 2022 | 4.44% |
| Mar 31, 2022 | 15.28% |
| Dec 31, 2017 | 38.30% |
| Sep 30, 2017 | 101.48% |
| Jun 30, 2017 | 150.68% |
| Mar 31, 2017 | 123.69% |
| Dec 31, 2014 | 94.04% |